ArticleResearch (Washington, D.C.)2026
Machine-Learning-Enabled Raman Spectroscopy Refines Indocyanine Green Fluorescence Boundaries for Precise Glioblastoma Margin Delineation.
Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Single-cell RNA sequencing combined with artificial intelligence to uncover immunotherapy biomarkers and decipher drug resistance mechanisms in glioblastoma.Frontiers in oncology · 2026Review
- MRI-Based Deep Learning Guides Multi-Omics Discovery of NBPF4 as a Therapeutic Target for Breast Cancer Lymph Node Metastasis.Research (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraoperative cancer diagnosis using Raman spectroscopy is a growing area of research, but clinical adoption is held back by relatively slow single point data acquisition. Its application to glioblastoma is particularly attractive because of the distinct spectra of malignant and healthy brain tissues, which allow detection of even diffusely invasive glioblastoma with high accuracy. Current clinical practice for intraoperative guidance uses indocyanine green (ICG) for wide-field localization, but its nonspecific accumulation beyond tumor margins leads to false-positive guidance. Critically, the strong fluorescence background from ICG under 785-nm Raman excitation overwhelms the inherently weak Raman signal, thereby preventing concurrent use of the 2 modalities. Here, we overcome this barrier by introducing a signal-processing algorithm that suppresses ICG-derived interference, enabling coregistered acquisition. We present an integrated "search-and-confirm" workflow, where ICG first identifies regions of interest and subsequent signal processing suppresses fluorescence interference, thereby enabling machine-learning-based Raman diagnosis within 3 s and achieving 85% to 90% identification accuracy in vivo. By enabling spatial correlation, we demonstrate that ICG systematically overestimates tumor extent, while Raman signatures match histopathological margins, thereby transforming Raman spectroscopy into a real-time corrective filter for clinical fluorescence guidance and offering a practical path toward precision glioblastoma resection.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.